Roxithromycin

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Definition
This section has been translated automatically.

Half-life
This section has been translated automatically.

13 h

Spectrum of action
This section has been translated automatically.

Bacterioides ureolyticus, Bordetella spp., Borrelia burgdorferi, Chlamydia, Clostridium spp. (except C. difficile), Corynebacterium diphtheriae, Entamoeba histolytica, Gardnerella vaginalis, Haemophilus ducreyi, Helicobacter pylori, Legionella pneumophilia, Listeria monocytogenes, Mobiluncus spp, Moraxella catarrhalis, Mycoplasma pneumoniae, Neisseria, Peptostreptococcus spp., Prevotella spp., Propionibacterium acnes, Staphylococcus spp., Streptococcus spp., Ureaplasma urealyticum.

Indication
This section has been translated automatically.

Limited indication
This section has been translated automatically.

Hypersensitivity to the active substance, liver dysfunction.

Dosage and method of use
This section has been translated automatically.

2 times/day 300 mg p.o. at least 15 minutes before meals.

Undesirable effects
This section has been translated automatically.

S.u. Erythromycin. Gastrointestinal NW are less pronounced.

Interactions
This section has been translated automatically.

No WW with oral anticoagulants, Ciclosporin A and Carbamazepine, otherwise see Erythromycin

Contraindication
This section has been translated automatically.

Pregnancy.

Preparations
This section has been translated automatically.

Rulide, Roxithromycin-ratiopharm

Authors

Last updated on: 29.10.2020